New drug BT-114143 passes first safety check in healthy volunteers

NCT ID NCT07169240

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-stage trial tested a single injection of BT-114143 in 84 healthy adults to see if it is safe and how the body handles it. Participants received different doses or a placebo, and researchers monitored side effects and drug levels in the blood. Since this is a Phase 1 study in healthy people, it does not test whether the drug treats any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BT-114143 injection

What could go wrong

This is a very early Phase 1 study in healthy people, so it cannot show whether BT-114143 works for any disease. The drug may cause side effects or fail in later trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • PKU Care Luzhong Hospital

    Zibo, Shandong, 255499, China